DEPOMED INC's ticker is and the CUSIP is 249908AA2. A total of 50 filers reported holding DEPOMED INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $2,236,000 | +0.1% | 3,000,000 | 0.0% | 0.14% | -6.5% |
Q3 2019 | $2,234,000 | +2.5% | 3,000,000 | 0.0% | 0.15% | -0.6% |
Q2 2019 | $2,179,000 | -4.8% | 3,000,000 | 0.0% | 0.16% | +70.3% |
Q1 2019 | $2,289,000 | +70.1% | 3,000,000 | +50.0% | 0.09% | +31.9% |
Q4 2018 | $1,346,000 | -49.2% | 2,000,000 | -33.3% | 0.07% | -33.0% |
Q2 2017 | $2,651,000 | -29.3% | 3,000,000 | -25.0% | 0.10% | -41.8% |
Q1 2017 | $3,751,000 | +30.5% | 4,000,000 | +60.0% | 0.18% | +12.0% |
Q4 2016 | $2,875,000 | -83.6% | 2,500,000 | -79.6% | 0.16% | -71.5% |
Q3 2016 | $17,518,000 | -3.4% | 12,250,000 | -18.3% | 0.55% | -26.2% |
Q2 2016 | $18,126,000 | -3.4% | 15,000,000 | -25.2% | 0.75% | -35.3% |
Q1 2016 | $18,770,000 | +534.3% | 20,041,000 | +75.2% | 1.16% | +843.1% |
Q4 2015 | $2,959,000 | +4.0% | 11,440,000 | +7235.4% | 0.12% | +30.9% |
Q3 2015 | $2,846,000 | -65.3% | 155,956 | -94.8% | 0.09% | -64.0% |
Q4 2014 | $8,207,000 | +3.0% | 3,000,000 | -60.0% | 0.26% | -12.7% |
Q3 2014 | $7,970,000 | – | 7,500,000 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Context Capital Management, LLC | 5,500,000 | $4,633,000 | 2.75% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 27,019,000 | $22,776,000 | 0.90% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 12,500,000 | $10,563,000 | 0.80% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 51,016,000 | $42,853,000 | 0.76% |
UBS OCONNOR LLC | 41,000,000 | $34,203,000,000 | 0.61% |
Man Investments (CH) AG | 600,000 | $508,000 | 0.48% |
ADVENT CAPITAL MANAGEMENT /DE/ | 20,534,000 | $17,398,000 | 0.33% |
Senvest Management, LLC | 5,000,000 | $4,228,000 | 0.30% |
CQS Cayman LP | 4,706,000 | $4,036,000 | 0.26% |
CSS LLC/IL | 4,436,000 | $3,755,000 | 0.18% |